Product Description
Product Name: Rituximab Injection
Strength: 500 mg/50 mL
Form: Concentrate for Intravenous Infusion
Category: Monoclonal Antibody / Anti-CD20 Agent
Indication: Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA)
Rituximab 500 mg Injection is a chimeric monoclonal antibody directed against the CD20 antigen found on the surface of B lymphocytes. It is used in the treatment of hematological malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune conditions including rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.
